PROMIS NEUROSCIENCES INC. Interest Expense, Other
PROMIS NEUROSCIENCES INC. (PMN) reported Interest Expense, Other of $76.78 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2026-03-25
- PROMIS NEUROSCIENCES INC. interest expense, other for the quarter ending 2023-12-31 was $76.80K.
- PROMIS NEUROSCIENCES INC. interest expense, other for the quarter ending 2023-09-30 was $75.41K.
- PROMIS NEUROSCIENCES INC. interest expense, other for the quarter ending 2023-06-30 was $49.18K.
- PROMIS NEUROSCIENCES INC. interest expense, other for fiscal 2024 was $76.78K, a 61.88% decline from fiscal 2023.
- PROMIS NEUROSCIENCES INC. interest expense, other for fiscal 2023 was $201.39K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month |
|---|---|---|---|---|
| 2024-12-31 | $76.78K 10-K · filed 2026-03-25 | |||
| 2023-12-31 | $76.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $152.21K derived: sum of 2 quarters · filed 2025-03-31 | $201.39K derived: sum of 3 quarters · filed 2025-03-31 | $201.39K 10-K · filed 2025-03-31 |
| 2023-09-30 | $75.41K 10-Q · filed 2023-11-14 | $124.59K derived: sum of 2 quarters · filed 2023-11-14 | $124.59K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $49.18K 10-Q · filed 2023-08-14 | $49.18K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |